Advances in targeted therapy of cholangiocarcinoma

Advances in targeted therapy of cholangiocarcinoma

AbstractCholangiocarcinoma (CCA) is a malignant tumor originating in the bile duct and its branching epithelium. Due to its high heterogeneity, there are no specific clinical indications at the early stage, the diagnosis is often in advanced CCA. With surgical resection, the 5-year postoperative sur...

Full description

Bibliographic Details
Main Authors: Yuhang Li, Jianfeng Yu, Yujing Zhang, Chuang Peng, Yinghui Song, Sulai Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Annals of Medicine
Subjects:
Cholangiocarcinoma
targeted therapy
treatment
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2024.2310196

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2024.2310196

Similar Items